- 专利标题: Biomarkers for diagnosis and prognosis of corneal ectatic disorders
-
申请号: US15551386申请日: 2016-02-16
-
公开(公告)号: US10914746B2公开(公告)日: 2021-02-09
- 发明人: María Isabel Lema Gesto , José Antonio Castillo Sánchez , Tomás Sobrino Moreiras , Francisco Campos Perez
- 申请人: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA , SERVIZO GALEGO DE SAUDE (SERGAS)
- 申请人地址: ES A Coruña; ES A Coruña
- 专利权人: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA,SERVIZO GALEGO DE SAUDE (SERGAS)
- 当前专利权人: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA,SERVIZO GALEGO DE SAUDE (SERGAS)
- 当前专利权人地址: ES A Coruña; ES A Coruña
- 代理机构: Thompson Coburn LLP
- 代理商 William A. Holtz
- 优先权: EP15382060 20150216
- 国际申请: PCT/EP2016/053293 WO 20160216
- 国际公布: WO2016/131840 WO 20160825
- 主分类号: G01N33/50
- IPC分类号: G01N33/50 ; G01N33/53 ; G01N33/577 ; G01N33/68 ; C12Q1/68 ; C07K14/705 ; C12Q1/6876
摘要:
The invention relates to the field of the diagnosis and prognosis methods of molecular pathologies. In particular, the invention relates to methods for determining the diagnosis of an ectatic disease of the cornea in a subject, for determining the risk of developing an ectatic disease of the cornea in a subject, for determining the clinical outcome of a subject suffering from an ectatic disease of the cornea and for selecting a subject to be treated with a therapy for an ectatic disease of the cornea based on the determination of the expression levels of TLR2 and/or TLR4 markers. The invention also relates to the use of the TLR2 and/or TLR4 as diagnosis and prognosis markers for an ectatic disease of the cornea.